Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Sep;48(9):1031-6.
doi: 10.1038/ng.3623. Epub 2016 Aug 1.

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

Craig L Hyde  1 , Michael W Nagle  2 , Chao Tian  3 , Xing Chen  1 , Sara A Paciga  2 , Jens R Wendland  2 , Joyce Y Tung  3 , David A Hinds  3 , Roy H Perlis  4 , Ashley R Winslow  2
Affiliations
Comparative Study

Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

Craig L Hyde et al. Nat Genet. 2016 Sep.

Abstract

Despite strong evidence supporting the heritability of major depressive disorder (MDD), previous genome-wide studies were unable to identify risk loci among individuals of European descent. We used self-report data from 75,607 individuals reporting clinical diagnosis of depression and 231,747 individuals reporting no history of depression through 23andMe and carried out meta-analysis of these results with published MDD genome-wide association study results. We identified five independent variants from four regions associated with self-report of clinical diagnosis or treatment for depression. Loci with a P value <1.0 × 10(-5) in the meta-analysis were further analyzed in a replication data set (45,773 cases and 106,354 controls) from 23andMe. A total of 17 independent SNPs from 15 regions reached genome-wide significance after joint analysis over all three data sets. Some of these loci were also implicated in genome-wide association studies of related psychiatric traits. These studies provide evidence for large-scale consumer genomic data as a powerful and efficient complement to data collected from traditional means of ascertainment for neuropsychiatric disease genomics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Discovery phase meta-analysis of 23andMe self-report ascertainment of major depression (75,607 cases and 231,747 controls) and PGC MDD (9,240 cases and 9,519 controls). a) Manhattan plot of Discovery phase 23andMe GWAS. LD score regression calculated intercept was used for inflation correction. The threshold for genome-wide significance (p < 5×10−8) is indicated by the purple line. Red dots represent SNPs with p-values smaller than the genome-wide significant threshold. Regions labeled in black denote loci that reached genome-wide significance in the join-analysis. b) Q-Q plot for the 23andMe MDD GWAS.
Figure 2
Figure 2
Regional association plots for genome-wide significant regions and secondary independent signals identified in each region. a) OLFM4 locus (rs12552), b) TMEM161B-MEF2C (rs10514299), c) MEIS2-TMCO5A locus (rs8025231), and d) NEGR1 locus (rs11209948). Secondary signals in TMEM161B-MEF2C and NEGR1 (rs454214, rs2422321 respectively) are shown. Purple diamonds represent smallest p-value for each locus.
See this image and copyright information in PMC

Similar articles

  • A mega-analysis of genome-wide association studies for major depressive disorder.
    Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium; Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, Breen G, Byrne EM, Blackwood DH, Boomsma DI, Cichon S, Heath AC, Holsboer F, Lucae S, Madden PA, Martin NG, McGuffin P, Muglia P, Noethen MM, Penninx BP, Pergadia ML, Potash JB, Rietschel M, Lin D, Müller-Myhsok B, Shi J, Steinberg S, Grabe HJ, Lichtenstein P, Magnusson P, Perlis RH, Preisig M, Smoller JW, Stefansson K, Uher R, Kutalik Z, Tansey KE, Teumer A, Viktorin A, Barnes MR, Bettecken T, Binder EB, Breuer R, Castro VM, Churchill SE, Coryell WH, Craddock N, Craig IW, Czamara D, De Geus EJ, Degenhardt F, Farmer AE, Fava M, Frank J, Gainer VS, Gallagher PJ, Gordon SD, Goryachev S, Gross M, Guipponi M, Henders AK, Herms S, Hickie IB, Hoefels S, Hoogendijk W, Hottenga JJ, Iosifescu DV, Ising M, Jones I, Jones L, Jung-Ying T, Knowles JA, Kohane IS, Kohli MA, Korszun A, Landen M, Lawson WB, Lewis G, Macintyre D, Maier W, Mattheisen M, McGrath PJ, McIntosh A, McLean A, Middeldorp CM, Middleton L, Montgomery GM, Murphy SN, Nauck M, Nolen WA, Nyholt DR, O'Donovan M, Oskarsson H, Pedersen N, Scheftner WA, Schulz A, Schulze TG, Shyn SI, Sigurdsson E, Slager … See abstract for full author list ➔ Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, et al. Mol Psychiatry. 2013 Apr;18(4):497-511. doi: 10.1038/mp.2012.21. Epub 2012 Apr 3. Mol Psychiatry. 2013. PMID: 22472876 Free PMC article.
  • Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts.
    Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, Antoniades A, Domenici E, Perry J, Rothen S, Vandeleur CL, Mooser V, Waeber G, Vollenweider P, Preisig M, Lucae S, Müller-Myhsok B, Holsboer F, Middleton LT, Roses AD. Muglia P, et al. Mol Psychiatry. 2010 Jun;15(6):589-601. doi: 10.1038/mp.2008.131. Epub 2008 Dec 23. Mol Psychiatry. 2010. PMID: 19107115
  • Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.
    Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM, Garriock HA, Yokoyama JS, McGrath PJ, Peters EJ, Scheftner WA, Coryell W, Lawson WB, Jancic D, Gejman PV, Sanders AR, Holmans P, Slager SL, Levinson DF, Hamilton SP. Shyn SI, et al. Mol Psychiatry. 2011 Feb;16(2):202-15. doi: 10.1038/mp.2009.125. Epub 2009 Dec 29. Mol Psychiatry. 2011. PMID: 20038947 Free PMC article.
  • Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder.
    Li X, Luo Z, Gu C, Hall LS, McIntosh AM, Zeng Y, Porteous DJ, Hayward C, Li M, Yao YG, Zhang C, Luo XJ; 23andMe Research Team7. Li X, et al. Neuropsychopharmacology. 2018 Sep;43(10):2146-2153. doi: 10.1038/s41386-018-0078-9. Epub 2018 Apr 27. Neuropsychopharmacology. 2018. PMID: 29728651 Free PMC article. Review.
  • Unraveling the genetic architecture of major depressive disorder: merits and pitfalls of the approaches used in genome-wide association studies.
    Schwabe I, Milaneschi Y, Gerring Z, Sullivan PF, Schulte E, Suppli NP, Thorp JG, Derks EM, Middeldorp CM. Schwabe I, et al. Psychol Med. 2019 Dec;49(16):2646-2656. doi: 10.1017/S0033291719002502. Epub 2019 Sep 27. Psychol Med. 2019. PMID: 31559935 Free PMC article. Review.
See all similar articles

Cited by

  • Neuroimaging and DNA Methylation: An Innovative Approach to Study the Effects of Early Life Stress on Developmental Plasticity.
    Mariani Wigley ILC, Mascheroni E, Peruzzo D, Giorda R, Bonichini S, Montirosso R. Mariani Wigley ILC, et al. Front Psychol. 2021 May 17;12:672786. doi: 10.3389/fpsyg.2021.672786. eCollection 2021. Front Psychol. 2021. PMID: 34079501 Free PMC article.
  • Genetic Architecture of Depression: Where Do We Stand Now?
    Unal-Aydin P, Aydin O, Arslan A. Unal-Aydin P, et al. Adv Exp Med Biol. 2021;1305:203-230. doi: 10.1007/978-981-33-6044-0_12. Adv Exp Med Biol. 2021. PMID: 33834402
  • Epigenomic profiling of primate lymphoblastoid cell lines reveals the evolutionary patterns of epigenetic activities in gene regulatory architectures.
    García-Pérez R, Esteller-Cucala P, Mas G, Lobón I, Di Carlo V, Riera M, Kuhlwilm M, Navarro A, Blancher A, Di Croce L, Gómez-Skarmeta JL, Juan D, Marquès-Bonet T. García-Pérez R, et al. Nat Commun. 2021 May 25;12(1):3116. doi: 10.1038/s41467-021-23397-1. Nat Commun. 2021. PMID: 34035253 Free PMC article.
  • Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders.
    Blokland GAM, Grove J, Chen CY, Cotsapas C, Tobet S, Handa R; Schizophrenia Working Group of the Psychiatric Genomics Consortium; St Clair D, Lencz T, Mowry BJ, Periyasamy S, Cairns MJ, Tooney PA, Wu JQ, Kelly B, Kirov G, Sullivan PF, Corvin A, Riley BP, Esko T, Milani L, Jönsson EG, Palotie A, Ehrenreich H, Begemann M, Steixner-Kumar A, Sham PC, Iwata N, Weinberger DR, Gejman PV, Sanders AR, Buxbaum JD, Rujescu D, Giegling I, Konte B, Hartmann AM, Bramon E, Murray RM, Pato MT, Lee J, Melle I, Molden E, Ophoff RA, McQuillin A, Bass NJ, Adolfsson R, Malhotra AK; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium; Martin NG, Fullerton JM, Mitchell PB, Schofield PR, Forstner AJ, Degenhardt F, Schaupp S, Comes AL, Kogevinas M, Guzman-Parra J, Reif A, Streit F, Sirignano L, Cichon S, Grigoroiu-Serbanescu M, Hauser J, Lissowska J, Mayoral F, Müller-Myhsok B, Świątkowska B, Schulze TG, Nöthen MM, Rietschel M, Kelsoe J, Leboyer M, Jamain S, Etain B, Bellivier F, Vincent JB, Alda M, O'Donovan C, Cervantes P, Biernacka JM, Frye M, McElroy SL, Scott LJ, Stahl EA, Landén M, Hamshere ML, Smeland OB, Djurovic S, Vaaler AE, Andreassen OA; Major Depressive Disorder Working Grou… See abstract for full author list ➔ Blokland GAM, et al. Biol Psychiatry. 2022 Jan 1;91(1):102-117. doi: 10.1016/j.biopsych.2021.02.972. Epub 2021 Mar 23. Biol Psychiatry. 2022. PMID: 34099189 Free PMC article.
  • The genetic landscape of basal ganglia and implications for common brain disorders.
    Bahrami S, Nordengen K, Rokicki J, Shadrin AA, Rahman Z, Smeland OB, Jaholkowski PP, Parker N, Parekh P, O'Connell KS, Elvsåshagen T, Toft M, Djurovic S, Dale AM, Westlye LT, Kaufmann T, Andreassen OA. Bahrami S, et al. Nat Commun. 2024 Oct 1;15(1):8476. doi: 10.1038/s41467-024-52583-0. Nat Commun. 2024. PMID: 39353893 Free PMC article.
See all "Cited by" articles

References

    1. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord. 2002;68:167–81. - PubMed
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57. - PubMed
    1. Wittchen HU, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79. - PubMed
    1. Lichtenstein P, et al. Recurrence risks for schizophrenia in a Swedish national cohort. Psychol Med. 2006;36:1417–25. - PubMed
    1. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–92. - PubMed

Methods-only References

    1. Eriksson N, et al. Web-based, participant-driven studies yield novel genetic associations for common traits. PLoS Genet. 2010;6:e1000993. - PMC - PubMed
    1. Tung JY, et al. Efficient replication of over 180 genetic associations with self-reported medical data. PLoS One. 2011;6:e23473. - PMC - PubMed
    1. Genomes Project, C. et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56–65. - PMC - PubMed
    1. Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007;81:1084–97. - PMC - PubMed
    1. Fuchsberger C, Abecasis GR, Hinds DA. minimac2: faster genotype imputation. Bioinformatics. 2015;31:782–4. - PMC - PubMed

Publication types